LeslieAAndritsosMD

Hematology • Albuquerque, NM

Hematologic Oncology

Professor of Internal Medicine, Division of Hematology/Oncology, University of New Mexico Comprehensive Cancer Center

Join to view full profile

Dr. Andritsos is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Andritsos' full profile

Already have an account?

Office
1201 Camino de Salud
Albuquerque, NM 87102
Phone+1 505-272-4946
Is this information wrong?

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2001 - 2005
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1999 - 2001
University of Texas Medical Branch School of MedicineClass of 1999

Certifications & Licensure

NM State Medical License 2018 - 2025
MO State Medical License 2003 - 2023
OH State Medical License 2006 - 2019
AZ State Medical License 2005 - 2007
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

Alpha Omega Alpha
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Alvocidib in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Start of enrollment: 2006 Sep 01
Terminated
Phase 1
Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia. Start of enrollment: 2007 Apr 01
Completed
Phase 1
Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia Start of enrollment: 2010 Aug 01
Completed
Phase 1
Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers Start of enrollment: 2010 Nov 24
Completed
Phase 1
Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma Start of enrollment: 2012 Feb 09
Completed
Phase 1, Phase 2
Phase II MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated CLL, SLL or PLL Start of enrollment: 2014 Jan 17
Active, not recruiting
Phase 2
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer Start of enrollment: 2016 Jan 27
Recruiting
Join now to see all

Publications & Presentations

PubMed

4 citations
Hairy Cell Leukemia: Where Are We in 2023?
Andres Mendez-Hernandez, Krishna Moturi, Valeria Hanson, Leslie A Andritsos> ;Current Oncology Reports. 2023 Aug 1
1 citations
Impact of sex on outcomes in patients with hairy cell leukemia. An HCL patient data registry analysis.
Narendranath Epperla, Qiuhong Zhao, Mirela Anghelina, Jasmine Neal, James S Blachly, Kerry A Rogers, Gerard Lozanski, Christopher C Oakes, Seema A Bhat, Clive S Zent, ...> ;American Journal of Hematology. 2023 May 1
3 citations
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia.
Farhad Ravandi, Robert J Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Jacqueline C Barrientos, Seema A Bhat, James S Blachly, Alessandro Broccoli, Timoth...> ;Blood Cancer Journal. 2022 Dec 13
Corrigendum to "Patient-driven research: Initial results from a prospective health-related quality of life study performed at the request of patients living with hairy...
Mirela Anghelina, Michelle J Naughton, Qiuhong Zhao, Amy S Ruppert, Jasmine Neal, Kerry A Rogers, James S Blachly, Gerard Lozanski, Seema A Bhat, Eric Kraut, Narendran...> ;Leukemia Research. 2022 Oct 1
2 citations
Development of a distributed international patient data registry for hairy cell leukemia.
Leslie A Andritsos, Mirela Anghelina, Jasmine Neal, James S Blachly, Puneet Mathur, Omkar Lele, Claire Dearden, Sunil Iyengar, Matthew Cross, Clive S Zent, Kerry A Rog...> ;Leukemia & Lymphoma. 2022 Dec 1
Patient-driven research: Initial results from a prospective health-related quality of life study performed at the request of patients living with hairy cell leukemia.
Mirela Anghelina, Michelle J Naughton, Qiuhong Zhao, Amy S Ruppert, Jasmine Neal, Kerry A Rogers, James S Blachly, Gerard Lozanski, Seema A Bhat, Eric Kraut, Narendran...> ;Leukemia Research. 2022 Sep 1
2 citations
Cost-effectiveness and value of information analyses of Bruton's tyrosine kinase inhibitors in the treatment of relapsed or refractory mantle cell lymphoma in the Unit...
Neda Alrawashdh, Ali McBride, Marion Slack, Daniel Persky, Leslie Andritsos, Ivo Abraham> ;Journal of Managed Care & Specialty Pharmacy. 2022 Apr 1
34 citations
Phase 2 study of ibrutinib in classic and variant hairy cell leukemia.
Kerry A. Rogers, Leslie A. Andritsos, Lai Wei, Eric McLaughlin, Amy S. Ruppert, Mirela Anghelina, James S. Blachly, Timothy G. Call, Dai Chihara, Anees M. Dauki, Ling ...> ;Blood. 2021 Jun 24
16 citations
Hairy cell leukemia and COVID-19 adaptation of treatment guidelines.
Michael R. Grever, Leslie A. Andritsos, Versha Banerji, Jacqueline C. Barrientos, Seema A. Bhat, James S. Blachly, Timothy G. Call, Matthew Cross, Claire Dearden, Judi...> ;Leukemia. 2021 May 4
12 citations
A Phase 1b Study to Evaluate the Safety and Efficacy of Durvalumab in Combination with Tremelimumab or Danvatirsen in Patients with Relapsed or Refractory Diffuse Larg...
Vincent Ribrag, Seung Tae Lee, David A. Rizzieri, Martin J. S. Dyer, Luis Fayad, Razelle Kurzrock, Leslie A. Andritsos, Reda Bouabdallah, Amjad Hayat, Larry Bacon, Yu ...> ;Clinical Lymphoma, Myeloma & Leukemia. 2021 May 1
9 citations
Current and Emerging Therapeutic Options for Hairy Cell Leukemia Variant.
Nicholas Harris, Narendranath Epperla, Leslie A. Andritsos> ;Oncotargets and Therapy. 2021 Mar 9
3 citations
Early Intervention with Lenalidomide in Patients with High-risk Chronic Lymphocytic Leukemia.
Shanmugapriya Thangavadivel, Qiuhong Zhao, Narendranath Epperla, Lindsey Allison Rike, Xiaokui Mo, Mohamed Badawi, Darlene M. Bystry, Mitch A. Phelps, Leslie A. Andrit...> ;Clinical Cancer Research. 2020 Sep 21
1 citations
Natural history of noninfectious, ibrutinib-attributable adverse events in patients with chronic lymphocytic leukemia
Soun Khountham, Polina Shindiapina, Xiaokui Mo, Curtis Lachowiez, Tracy Wiczer, Luay Mousa, Kerry A. Rogers, Leslie A. Andritsos, Jennifer A. Woyach, John C. Byrd, Ste...> ;Leukemia & Lymphoma. 2021 Feb 23
5 citations
Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemia.
Nyla A. Heerema, Natarajan Muthusamy, Qiuhong Zhao, Amy S. Ruppert, Heather Breidenbach, Leslie A. Andritsos, Michael R. Grever, Kami J. Maddocks, Jennifer A. Woyach, ...> ;Haematologica. 2020 May 15
6 citations
Adverse event rates and economic burden associated with purine nucleoside analogs in patients with hairy cell leukemia: a US population-retrospective claims analysis
Narendranath Epperla, Melissa Pavilack, Temitope Olufade, Richa Bashyal, Jieni Li, Shaum M Kabadi, Huseyin Yuce, Leslie A. Andritsos> ;Orphanet Journal of Rare Diseases. 2020 Feb 13
8 citations
Ruxolitinib In The Treatment Of Polycythemia Vera: An Update On Health-Related Quality Of Life And Patient-Reported Outcomes
Shashank Cingam, Lainey Flatow-Trujillo, Leslie A. Andritsos, Cecilia Arana Yi> ;Journal of Blood Medicine. 2019 Nov 14
6 citations
Spontaneous resolution of untreated diffuse large B-cell lymphoma of maxillary bone after incisional biopsy.
Lainey Flatow‐Trujillo, Khine Win, Amy Jencks, Leslie A. Andritsos, Cecilia Arana Yi> ;Clinical Case Reports. 2019 Sep 27
84 citations
Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)–an expert opinion from the European Society for Blood an...
Ankit Kansagra, Noelle V. Frey, Merav Bar, Theodore W. Laetsch, Paul A. Carpenter, Bipin N. Savani, Helen E. Heslop, Catherine M. Bollard, Krishna V. Komanduri, Dennis...> ;Bone Marrow Transplantation. 2019 Nov 1
9 citations
Clinical and cost outcomes of pre-emptive plerixafor administration in patients with multiple myeloma undergoing stem cell mobilization
Leslie A. Andritsos, Ying Huang, Ivo Abraham, Keith Huff, Scott Scrape, Tao Fan, Nimer S. Alkhatib, Craig C. Hofmeister, Edward Drea, Ali McBride> ;Leukemia Research. 2019 Aug 9
15 citations
A multicenter phase 1 study of plerixafor and rituximab in patients with chronic lymphocytic leukemia.
Leslie A. Andritsos, John C. Byrd, Peter Cheverton, Jingyang Wu, Mariela Sivina, Thomas J. Kipps, Jan A. Burger> ;Leukemia & Lymphoma. 2019 Jul 27
8 citations
BEAM versus BUCYVP16 Conditioning before Autologous Hematopoietic Stem Cell Transplant in Patients with Hodgkin Lymphoma.
Sara Singer, Robert M. Dean, Qiuhong Zhao, Nidhi Sharma, Donna Abounader, Patrick Elder, Craig C. Hofmeister, Don M. Benson, Ashley E. Rosko, Sam Penza, Leslie A. Andr...> ;Biology of Blood and Marrow Transplantation. 2019 Jun 1
2 citations
Transplant-associated thrombotic microangiopathy: is the treatment more expensive than the disease?
John L Vaughn, Qiuhong Zhao, Narendranath Epperla, Marcin Puto, Julianna Roddy, Patrick Elder, William Blum, Rebecca B. Klisovic, Samantha Jaglowski, Sam Penza, Basem ...> ;Bone Marrow Transplantation. 2019 Jun 1
1 citations
Cutaneous adverse events associated with purine analogs in the treatment of hairy cell leukemia.
Rebecca F. Wang, Gina J. Kuehn, Leslie A. Andritsos, Michael R. Grever, Benjamin H. Kaffenberger> ;International Journal of Dermatology. 2019 May 1
23 citations
Use of PD‐1 (PDCD1) inhibitors for the treatment of Richter syndrome: experience at a single academic centre
Kerry A. Rogers, Ying Huang, Emily Dotson, Jordan Lundberg, Leslie A. Andritsos, Farrukh T. Awan, Jennifer A. Woyach, John C. Byrd> ;British Journal of Haematology. 2019 Apr 1
90 citations
Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Tran...
Ankit Kansagra, Noelle V. Frey, Merav Bar, Theodore W. Laetsch, Paul A. Carpenter, Bipin N. Savani, Helen E. Heslop, Catherine M. Bollard, Krishna V. Komanduri, Dennis...> ;Biology of Blood and Marrow Transplantation. 2019 Mar 1
Join now to see all

Lectures

Infection at the Time of Initial Therapy for Hairy Cell Leukemia Is Associated with Inferior Time to Next Treatment
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Professional Memberships

American College of Physicians - ACP
Member
American Society of Hematology - ASH
Member
American Association for Cancer Research - AACR
Member
American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

University of New Mexico HospitalsAlbuquerque, New Mexico